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Department of Biochemistry and Biophysics, University of Rochester, Rochester, New YorkABSTRACT Bacteria, particularly of the genus Bacillus, produce a wide variety of antifungal compounds. They act by affecting
the lipid bilayers of fungal membranes, causing curvature-induced strain and eventual permeabilization. One class of these,
known as fengycins, has been commercialized for treating agricultural infections and shows some promise as a possible anti-
fungal pharmaceutical. Understanding the mechanism by which fengycins damage lipid bilayers could prove useful to the future
development of related antifungal treatments. In this work, we present multi-microsecond-long simulations of fengycin interact-
ing with different lipid bilayer systems. We see fengycin aggregation and uncover a clear aggregation pattern that is partially
influenced by bilayer composition. We also quantify some local bilayer perturbations caused by fengycin binding, including cur-
vature of the lipid bilayer and local electrostatic-driven reorganization.INTRODUCTIONFengycin, a class of lipopeptides originally isolated in
Bacillus subtilis (1), has shown promise as an antifungal
agent for use in controlling plant disease (2). Natural fengy-
cins expressed from a variety of bacterial strains have been
used to treat many agricultural infections: clubroot disease
(Plasmodiophora brassicae) in cruciferous plants (3), maize
rot (Fusarium moniliforme) (4), barley head blight (Fusa-
rium graminearum) (5), and black bread mold (Rhizopus
stolonifer) (6). The potential for fengycin use as a major
agricultural tool has been enhanced by the development of
protocols for maximizing fengycin synthesis in strains of
Bacillus subtilis (7), and it has been commercialized as
the green antifungal product Serenade (AgraQuest, Davis,
CA). It also has hemolytic activity lower than other agents
(8), making it a strong candidate as a novel pharmaceutical
for treating fungal infections.
There are multiple possible mechanisms for fengycin
action. It has been shown that similar peptides, particularly
surfactins, stimulate natural plant responses to infection (9)
and may have an effect on quorum-sensing (10). They also
serve as powerful biosurfactants capable of inducing cell
lysis (11) and membrane leakage (12).
The focus of this work will be on the membrane permea-
bilization mechanism. Fengycin has been shown to perturb
DPPC monolayers in a dose-dependent manner (13), affect
the mixing properties of monolayers (1), and alter the for-
mation of lipid domains (14). However, experimental
methods to date have not characterized the near-atomic in-
teractions involved in these membrane perturbations.
Molecular dynamics simulation (MD) has long been used
to address a variety of problems in membrane biophysics
(15,16), including the substantial body of work simulatingSubmitted July 9, 2013, and accepted for publication August 22, 2013.
*Correspondence: alan_grossfield@urmc.rochester.edu
Editor: Heiko Heerklotz.
 2013 by the Biophysical Society
0006-3495/13/10/1612/12 $2.00membrane proteins (17) like G protein-coupled receptors
(18–20) and membrane transporters (21). Furthermore, a
number of groups have used MD to quantify and analyze in-
teractions between antimicrobial peptides and lipids in bila-
yers (22,23). Most of these studies used all-atom molecular
dynamics, which explicitly represents every atom in the sys-
tem. Although this approach has remarkable resolution in
time and space, and arguably represents the gold standard
for biomolecular simulation, it can be prohibitively expen-
sive computationally to obtain adequate statistical sampling
because of the large conformational space available to anti-
microbial peptides, especially those that require the aggre-
gation of multiple molecules and large patches of bilayer.
To overcome this challenge, coarse-grained models have
been employed. In these models, subsets of atoms are
abstracted into functional units and treated as a single
bead that attempts to represent the underlying atoms. By
reducing the quantity of degrees of freedom, there are fewer
interactions to compute and it is possible to use a larger time
step for integrating the equations of motion. One such
model, the MARTINI force field (24), reduces computa-
tional costs by roughly two orders of magnitude relative to
comparable all-atom models. As a result, it is one of the
more common models for bilayer simulations and has
been used to address a number of membrane problems,
including vesicle fusion (25), phase behavior (26), and the
formation of lipid domains (27). This model has also been
used extensively in the study of antimicrobial peptides
that interact with lipid bilayers and alter bilayer properties
(28–32), including cyclic peptides (33).
In this study, we explore the structure and aggregation of
fengycin interacting with different model membrane com-
positions using coarse-grained MD, and analyze its effects
on bilayer structure to propose a mechanism for its function.
Specifically, fengycin’s tendency to aggregate is sensitive tohttp://dx.doi.org/10.1016/j.bpj.2013.08.034
Fengycin-Bilayer Interactions 1613the composition of the bilayer, and this in turn modulates its
ability to induce membrane curvature.METHODS
System construction
The coarse-grained force-field MARTINI, Ver. 2.1 (University of Gronin-
gen, Groningen, Netherlands), was used to describe the interactions in
our system (24,34,35). We chose a fengycin structure that has been noted
previously in Wu et al. (36) and has been recently characterized by mass
spectrometry (37). With a glutamate at position 8, it differs from fengycin
IX (38) and fengycin A2, which have a glutamine at that position. Because
of this, our structure has a net negative charge, whereas these other fengy-
cins tend to be neutral. Due to a lack of available PDB structures, we built a
MARTINI model for this structure by hand, shown in Fig. 1. The ornithine
residue was constructed by copying a lysine residue and shortening the
bond length between the backbone bead and the first bead of the side chain
(from 0.33 nm in lysine to 0.31 nm in our ornithine).To build the lipopeptide-free bilayer systems, we began with a 128-lipid
dipalmitoyl phosphatidylcholine (DPPC) bilayer system available at the
MARTINI website. We tessellated this system to create a 512-lipid system
and equilibrated it for 400 ns. This bilayer was converted to a pure palmi-
toyl oleoyl phosphatidylcholine (POPC) bilayer by adding one bead and
double bond character to a tail in each lipid, converting one chain from
a palmitoyl to oleoyl. This bilayer was also converted to a 2:1 mixture
of palmitoyl oleoyl phosphatidylethanolamine (POPE) and palmitoyl
oleoyl phosphatidylglycerol (POPG). The conversion of palmitoyl to
oleoyl was accomplished as before, although the headgroup change was
accomplished by changing the identity of the positive headgroup
bead (PC, PE, and PG all contain the same number of MARTINI beads).
Lipids were randomly chosen to become PE or PG, such that both leaflets
had the same 2:1 PE/PG composition. This process was performed again
for each replicate of the system; the resulting snapshots were then equili-
brated for 300 ns.
We built single-fengycin systems by adding a fengycin molecule to each
equilibrated lipid system and simulating until fengycin bound to the bilayer.
We simulated fengycin bound in each bilayer for another 100 ns, chose 16
frames post-binding from each system trajectory, gave them new velocities,FIGURE 1 (A) Chemical structure of our fengy-
cin of interest. Also shown are space-filling repre-
sentations shown from the top and side of fengycin
with (B) all-atom resolution and our (C) coarse-
grained representation. (For the all-atom model,
the atoms are colored using green for carbons,
white for hydrogens, red for oxygens, and blue
for nitrogens. In the coarse-grained model, yellow
is used for tail beads, green for peptide backbone
beads, and white for amino-acid side chains. In
both representations, a black backbone trace of
the coarse-grained model is shown for reference.)
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1614 Horn et al.and restarted from these frames. The result was a set of 16 independent sys-
tems for each bilayer with one fengycin bound.
Fengycin’s amphipathicity suggested that it would likely aggregate in so-
lution, sequestering the hydrocarbon chain away from solution. With this in
mind, we built aggregates of fengycin by randomly placing fengycin mol-
ecules in solution and running for 100 ns, at which point a loose micelle had
formed that persisted for some time. We excised this 13-fengycin aggregate
from the system and placed it into the equilibrated POPE/POPG bilayer sys-
tem with water and salt; in addition to neutralizing salt, we added enough
NaCl to set the free salt concentration at ~100 mM. A weak harmonic po-
tential was applied to move the micelle toward the bilayer until they were in
contact. Copies of this system were made and the POPE and POPG lipids
were converted to POPC and DPPC lipids (using the same procedure
described above) to give us all three lipid compositions with a fengycin
micelle bound. These systems were energy-minimized and equilibrated
for a nanosecond. Sixteen replicas of each system were given unique start-
ing velocities to create 16 independent trajectories. In these simulations, the
lipopeptides rapidly insert into the bilayer. Again, we focused on the
behavior of lipopeptides after insertion, ignoring the binding process.Simulation protocol
These simulations were run using Ver. 4.5.5 of the GROMACS simulation
package (39,40). We employed a time step of 20 fs with the neighbor list up-
dated every 5 steps. We held the temperature at 300 K for the POPC and
POPE/POPG systems and 323 K for the DPPC systems using Nose´-Hoover
temperature coupling (41,42). Pressure was treated semiisotropically using
the Parrinello-Rahman barostat with a reference of 1 bar (43). Electrostatics
were computed with a shift function with a cutoff of 12 A˚. Shift was used for
van der Waals, with a switch distance of 9 A˚ and a cutoff of 12 A˚.
Each simulation with fengycin is>2 ms long and lipopeptide-free bilayer
simulations are >1 ms long. There are nine distinct systems, each of which
was simulated 16 times, for a total of >252 ms of simulation time (a com-
plete list of systems and average simulation lengths can be found in Table S1
in the SupportingMaterial). This can be considered an effective total time of
greater than a millisecond when we consider the faster kinetics in the
MARTINI model (24); the times reported here are actual simulation times.Simulation analysis
All analysis was performed with tools developed with the Lightweight Ob-
ject Oriented Structure (LOOS) analysis library (44). LOOS is an object-
oriented library implemented in Cþþ that provides functionality for
creating new tools for the analysis of molecular dynamics simulations.
(LOOS is available for download at http://loos.sourceforge.net, licensed un-
der Ver. 3 of the GNU Project’s General Public License (GPL).) All analysis
was done on the trajectories at 100-ps resolution. The first 100 ns were
excluded from each trajectory as equilibration and to ensure that the lipo-
peptides were completely bound. Unless otherwise noted, error bars shown
on plots reflect the standard error computed with each trajectory treated as a
single independent data value.
Density distributions
The density distribution of lipopeptide residues along the membrane normal
was computed by binning counts of each residue’s backbone bead using
0.25 A˚ bins. Each histogram was shifted relative to the phosphate density
peak to make it easier to separate bilayer penetration from differences in
bilayer thickness.
Aggregation
To quantify fengycin aggregation, we calculated the contacts between mol-
ecules and we defined clusters of fengycin molecules based on these
criteria. Coarse-grained beads were considered in contact if they wereBiophysical Journal 105(7) 1612–1623spaced %6 A˚ apart. A pair of lipopeptides was considered members of
the same cluster if they had two or more contacts.
Cluster contact map
We described the interactions between aggregated fengycins by employing
a map of intermolecular residue-residue contacts. If two fengycin mole-
cules were clustered based on the criteria we defined for aggregation, we
checked every pairwise combination of intermolecular contacts for contact
(beads spaced<6 A˚). We report the likelihood that a given contact between
beads exists when two lipopeptides are clustered; a value of 1 indicates that
a given pair of atoms is always in contact when a pair of fengycins meets the
criteria for aggregation.
Radial distribution function
We computed a variety of radial distribution functions (RDF) to quantify
local enrichments in our system. For quantifying the lateral ordering of lipid
species about lipopeptides, we computed the RDF in the plane of the bilayer
only and treated each molecule as a single point, centered at the centroid.
For pairwise interactions between headgroup beads, the RDF was computed
in three dimensions.
Bilayer curvature
To quantify the curvature of the bilayer induced by fengycin, we created
maps measuring the height of the lipid phosphate beads relative to the cen-
ter of the lipid bilayer as a function of lateral distance from fengycin. We
began by hand-curating a collection of clusters from the 13 fengycin in
DPPC and POPC simulations. Details on the cluster curation process can
be found in the Supporting Material.
Each cluster was centered in the plane of the bilayer, and the axis of the
cluster (defined as the vector between the centroids of the terminal fengy-
cins) was aligned along the X axis. This allows clusters of the same size
from different simulations to be compared to one another. For each frame
of the simulations, we binned the heights of the phosphates in a grid on
the plane parallel to the membrane, with 1 A˚2 bins. This calculation was per-
formed for both the leaflet with lipopeptides bound (proximal) and the oppo-
site leaflet (distal) of the bilayer. The heights were normalized compared to
lipopeptide-free bilayers to make comparison between different lipid com-
positions possible. These data are presented as a heat map, with each bin
presented as the average height for all the phosphates in that bin.
We also calculated the phosphate heights as a function of distance from
each lipopeptide. Here we position each lipopeptide at the center of the
bilayer plane and bin the phosphate heights by their distance from the lip-
opeptide centroid. This calculation was done for both leaflets to show
whether the curvature is localized to one leaflet or is an effect across the
membrane.
Principal component order parameters
Because the chains do not contain all of the carbons, we cannot compute
order parameters that are directly comparable to the 2H quadrupolar split-
tings measured via solid-state nuclear magnetic resonance. However, we
can quantify lipopeptide-induced changes to bilayer structure through a
simplified order parameter. In this calculation, we compute the three prin-
cipal axes for each lipid palmitoyl chain; the first principal axis lies in the
direction of the chain, whereas the others define the plane perpendicular to
the chain. The angle between these other axes and the membrane normal
can be treated as mock carbon-hydrogen bonds to calculate the molecular
order parameter,
SCD ¼ 1
2

3 cos2 q 1; (1)
where q is the angle between the membrane normal and the second or third
principal axis. We binned these order parameters based on distance in the
plane of the bilayer from each lipopeptide in the same leaflet.
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Lipopeptide binding and orientation in bilayers
All of the simulations started with fengycin close to the
bilayer, and insertion always occurred within the 100-ns
equilibration period. As a result, all of the analysis presented
here is for the fully inserted state.
Fengycin’s orientation is largely the same in all three
bilayer compositions, with the palmitoyl chain toward the
interior of the bilayer, spanning one leaflet, and the peptide
ring interacting with the lipid headgroups and extending into
the solution. Fig. 2 shows normalized density distributions
along the membrane normal for each of the 10 amino-acid
residues of the fengycin chain in the DPPC system; for con-
venience, the distances are shifted such that z ¼ 0 is the
location of the peak of the lipid phosphate distribution.
For comparison, the density for the hydrocarbon tail is
shown as well, extending far below the phosphate peak
and tapering off just outside the peak ~z ¼ 2 A˚. Two hydro-
phobic residues have peaks inside the phosphate peak: the
tyrosine at position 9 and the isoleucine at position 10.
Most of the other amino acids, including the two amino
acids connected directly to the hydrocarbon tail and not
part of the ring (Glu1 and Orn2), have peaks within a win-
dow from 0 to 4 A˚ and interact primarily with the head-FIGURE 2 Normalized density of each fengycin residue relative to the
phosphate density peak for the DPPC systems with one fengycin. (Solid
and dashed lines represent residues with peaks below or above the phos-
phate peak, respectively.) Also shown is a snapshot from a simulation of
the fengycin peptide that fits the distribution in the plot (backbone beads
are shown as spheres; residues colored to match). Standard error was no
larger than 1% at any point (omitted for clarity).groups of the lipids. Two residues, the threonine at
position 4 and the glutamate at position 5, are both above
4 A˚, and are exposed to the water environment significantly
more than the rest of the peptide.
The entire lipopeptide is anchored by the hydrocarbon in-
serted into the hydrophobic bilayer interior. The ring of fen-
gycin is tilted in the headgroup region to accommodate the
insertion of Tyr9 and Ile10’s hydrophobic side chains into the
bilayer. On the other side of the ring, Thr4 and Glu5, with
polar side chains, are oriented toward the water outside
the bilayer. The rest of the residues fall along a tilted plane
between these two ends, resting primarily in the area of the
lipid headgroups. A snapshot from a trajectory in which the
fengycin ring fits this description and matches the density
plots well, can be found in Fig. 2.
The relative spacing of the residues is nearly identical for
the POPC and POPE/POPG systems (data not shown). How-
ever, there are subtle changes to fengycin’s overall posi-
tioning within the bilayer. It has been suggested that
DPPC’s tight packing and lower fluidity may result in shal-
lower lipopeptide penetration compared to bilayers with
lipids with unsaturated hydrocarbons (DOPC, for instance)
(14). In our simulations, we see a similar effect. This is
quantified in Fig. S1 in the Supporting Material, using the
normalized density distribution of the backbone beads for
the fengycin ring, again shifted relative to the peak of the
phosphate density. The peptide backbone of fengycin inserts
most deeply into POPC, followed by POPE/POPG, with
fengycin least deeply inserted into the DPPC bilayer.
Though the fengycin peptide density is shifted closer to
the bilayer center in the POPC system, most of the density
is still outside the phosphate peak. This implies that the pep-
tide interacts mostly with the lipid headgroups and the
aqueous environment, as opposed to the hydrophobic core
of the bilayer. This makes sense chemically, given the pre-
ponderance of polar side chains.Fengycin forms organized aggregates
Before building our bilayer systems, we began by simu-
lating multiple fengycins in water. The fengycins readily
formed micelles, which has been seen experimentally
(45), leading to our decision to place a fengycin micelle at
the surface of a lipid bilayer to explore the effect these
micelles have on membranes.
Visual inspection of our micelle-bilayer simulations sug-
gests that the preferred aggregation state of fengycin bound
to membrane is sensitive to the headgroup composition.
Fig. 3 quantifies this by showing the number of unique fen-
gycin clusters present in the simulations as a function of
time; because each simulation began with the 13 fengycins
in a single cluster, we expect the value to increase over time
simply for entropic reasons. Each curve is the average of 16
trajectories, with error bars representing the standard error
of the mean to highlight the degree of variation betweenBiophysical Journal 105(7) 1612–1623
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FIGURE 3 Average number of aggregates of fengycin over time for the
systems with 13 fengycins stabilized. To see this figure in color, go online.
1616 Horn et al.trajectories. Averaging the time series from independent tra-
jectories obscures the details of individual simulations but
highlights global trends. In this case, we see that the 13-fen-
gycin micelle falls apart into smaller clusters in all of the
systems. After 2 ms of simulation time the POPC and
DPPC systems have leveled off with an average of ~2 and
3 clusters per trajectory, respectively. This means that the
equilibrated clusters tend to be ~5–6 fengycins per cluster
in POPC bilayers and four fengycins in DPPC bilayers.
By contrast, the average number of clusters climbs to nearly
six clusters per trajectory in the POPE/POPG system, and
the absence of a pronounced plateau suggests that the true
equilibrium value is higher. It is possible that the monomer
is the most stable state when bound to the charged bacteria-
like membrane, although significantly longer simulations
would be necessary to prove this conclusively.
One interesting question is whether fengycin aggregation
is driven by specific interactions, or merely nonspecific
clustering. To answer it, we plot in Fig. 4 the average inter-
residue contact maps for clustered fengycins (see Methods
for details). It is shown as a probability heat map, with
bright spots corresponding to areas where two beads are
often in contact when two lipopeptides are in contact. The
maps for each of the different bilayer systems are qualita-
tively very similar, but the intensity of regions with high
contact differs in key ways. The region of highest contact
is Tyr3 (atoms 6–9). This is the tyrosine residue that con-
nects to the C-terminus of the peptide portion to close the
peptide ring. The map indicates that when fengycins are
in contact, it most frequently involves contact of their
Tyr3 residues. Panel D in Fig. 4 shows a sample cluster
with the Tyr3 side-chain beads shown as spheres to highlight
the stacking of Tyr3 residues and the linear aggregation of
fengycin molecules. This tyrosine is conserved among fen-
gycin and plipastatin variants (albeit with varying chirality).
However, it is not present in surfactins and is positioned
differently in iturins, all of which differ dramatically in their
aggregation properties, which suggests that this tyrosine is a
critical part of the unique aggregation mechanism of
fengycins.Biophysical Journal 105(7) 1612–1623Cryo-transmission electron microscopy data indicate that
fengycin forms a variety of aggregate structures in POPC
systems, including crystals, amorphous aggregates, and
fibers (46), leading us to suggest that the organized pattern
of aggregation in our simulations may be an early nucleation
structure. From visual inspection of the aggregates we can
see an alternating pattern within aggregates, where neigh-
boring lipopeptides in the chain are often rotated 180 rela-
tive to one another, with the opposite face of the ring
interacting. At fengycin concentrations slightly higher
than the one in our system (fengycin/lipid ratio of 0.026:1
compared to our 0.025:1), fengycin has been observed
experimentally beginning to form larger aggregates in
DPPC bilayers (14). The experiments show that aggregation
increases with higher concentration, and eventually higher-
order structures are stabilized.
The fengycin-packing pattern in POPE/POPG is similar
to that in DPPC and POPC, but less pronounced in the
Tyr3 region. In addition, areas outside of this region are
brighter in POPE/POPG. This leads us to believe that
whereas clusters tend to follow the described packing
pattern in the POPE/POPG system, fengycin contacts that
qualify as clusters by our criteria frequently involve
nonstandard interactions that are likely transient, as the clus-
ters (which are larger in number) move about in the lipid
bilayer.Preferential interactions with POPG lipids
Fig. 5 shows a radial distribution function (RDF) in the
plane of the bilayer for each lipid component, tracking their
distribution about fengycin. The DPPC and POPC curves
are not especially informative, because there is no other
lipid component for comparison in these pure bilayers.
However, the absence of a contact peak suggests the absence
of any strong specific structuring of lipid headgroups in the
vicinity of the peptide.
By contrast, the results for the POPE/POPG system reveal
striking (and surprising) effects on lateral ordering. In both
the single fengycin and the micelle systems, we see a pref-
erence for POPG lipids at short range. In the single fengycin
system, this preference is substantial and leads to the occlu-
sion of POPE at short range. In the 13-fengycin system, the
POPG preference is far less dramatic, and the POPE RDF is
not noticeably different from the DPPC and POPC curves.
The presence of other lipopeptides in that system and the
weak aggregates of 2–3 lipopeptides is probably washing
out the effect. The alternating pattern of fengycins within
clusters means that if there are preferential POPG interac-
tions sites on a single fengycin, the aggregate as a whole
likely has alternating interaction sites as well, convoluting
the RDF calculation for individual lipopeptides within this
context. Fengycin’s inability to exist in persistent clusters
within the POPE/POPG system is explained to some degree
by fengycin’s strong interactions with POPG lipids—by
A B
C
D
FIGURE 4 Bead-bead contact maps between
clustered fengycins for (A) DPPC, (B) POPC, and
(C) POPE/POPG bilayers. Residue sequences are
shown as axes, with the complete coarse-grained
bead list for the peptide portion of fengycin to
the right. (D) Also shown are two different views
for a representative cluster (palmitoyl chains in
yellow, backbones in green, side-chain tyrosine in
gray, and the three beads that make up the cyclic-
linking tyrosine in blue shades to show the orienta-
tion of packing).
Fengycin-Bilayer Interactions 1617dissolving the aggregates, each fengycin can maximize con-
tacts with these lipids.
The preferential interaction between POPG and fengycin
is at first very surprising, because a naive electrostatic inter-
pretation would suggest that the fengycin’s net 2 charge
would repel the anionic headgroup. To rationalize this phe-
nomenon, we computed three-dimensional RDFs between
the headgroups and specific components of the fengycin,
to figure out which interactions were stabilizing these inter-
actions. The headgroup beads of interest were the anionic
phosphate bead for POPE, the cationic amine for POPE
(which gives it zwitterionic character), the anionic phos-
phate bead for POPG, and the neutral glycerol for POPG.
Fig. 6 shows the RDFs, separated by the side chain used
as the center. For the ornithine, the RDFs appear exactly asA Bwe would expect. There are favorable interactions between
the positively charged ornithine bead and both beads of the
PG headgroup; these are presumably driven by favorable
electrostatics between the phosphate and the ornithine
(the covalent bond between the phosphate and glycerol
beads accounts for the apparent interaction between orni-
thine and glycerol). By contrast, the interaction with
POPE is very weak, likely because POPE tends to be dis-
placed by POPG.
The plots for Glu1 and Glu8 are similar to one another
and provide insight into fengycin’s overall POPG prefer-
ence. As expected, because of repulsive electrostatics, we
see little interaction with the phosphate groups from both
POPE and POPG. We do see favorable contact peaks for
both the POPE amine group (due to complementaryFIGURE 5 Lateral radial distribution of lipids as
a function of distance from lipopeptides in the
bound leaflet for systems with (A) one fengycin
and (B) 13 fengycins. To see this figure in color,
go online.
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FIGURE 6 Radial distribution of the headgroup
beads of PG and PE lipids relative to the charged
beads of (A) Orn2, (B) Glu1, (C) Glu5, and (D)
Glu8 in the POPE/POPG system with one fengycin.
1618 Horn et al.electrostatics) and the POPG glycerol—a strong polar inter-
action. For the glutamates, each lipid has both one preferen-
tial interaction and one repulsive. By contrast, the ornithine
residue has only attractive interactions with PG headgroups,
and this is sufficient to cause a net attraction to PG. Visual
inspection of the trajectories indicates that Glu1 and Glu8
are constantly close to Orn2, with the POPG lipids
frequently oriented in a way to maximize preferential inter-
actions between all involved residues.
The curves for Glu5 are qualitatively similar to the other
glutamates, but the peaks are significantly smaller. This
occurs because the layout of the fengycin ring places Glu5
farther from the membrane (see Fig. 2), where it interacts
mostly with water rather than the lipid headgroups.Curvature and perturbation of lipid bilayers
Fengycin’s size relative to common phospholipids suggests
that it would induce positive curvature in the lipid bilayer
and promote micelle formation (14). To quantify possible
fengycin-induced curvature, we computed the heights of
the lipid phosphate beads relative to the center of the bilayer
along the bilayer normal. It is shown in Fig. 7 as a heat map
for the bound and lipopeptide-free leaflets. We curated clus-
ters of six fengycins and nine fengycins for both the DPPC
and POPC systems. We could not do the same thing for
POPE/POPG because we could not find stable, persistent
clusters that were large enough.
We can see shifts in the phosphate heights for both leaflets
in all the systems shown. The shifts are positive increases in
both leaflets, toward the lipopeptides, suggesting positive
curvature in the bilayer. In Fig. 7, we also show an indicator
of the thickness of the bilayer, calculated by the differenceBiophysical Journal 105(7) 1612–1623between the leaflet maps, to see if the fengycins are inducing
bilayer-thinning. Fengycin appears to promote curvature of
both leaflets while slightly thinning the bilayer. (Sample tra-
jectory snapshots of fengycin clusters inducing bilayer cur-
vature are found in Fig. 8.)
These maps can be striking visual evidence for induced
curvature, but are difficult to quantify. As a followup, we
also calculated the phosphate heights as a function of dis-
tance from each lipopeptide. This allows us to include clus-
ters of every size in the micelle simulations to see if the
clustering has a general effect on curvature. The single fen-
gycin systems show very little bilayer perturbation, with the
largest differences between the phosphate peak and the
plateau of the curve measuring <1 A˚ (data not shown).
Fig. 9 shows the same quantity for both leaflets in the 13-
fengycin systems. The first microsecond of simulation was
omitted from the calculation so that we can compare the
effects after the clusters have equilibrated (this corresponds
with the plateaus in the DPPC and POPC aggregation
curves). The fengycin clusters have a much more dramatic
effect on the bilayer curvature. The phosphate peaks for
the POPC system show the greatest curvature. The peak-
to-plateau differences for the bound leaflet and the unbound
leaflet are 3.25 and 3.87 A˚, respectively. For DPPC, the dif-
ferences are 2.26 and 3.14 A˚ and for POPE/POPG, they are
2.05 and 2.34 A˚. It is clear that the curvature effect is depen-
dent on cluster size, because the mixed POPE/POPG sys-
tems show the smallest effect on the bilayer. These values
also allow us to quantify the weak bilayer thinning effect
that these clusters induce. By taking the difference between
the peak-to-plateau curvature changes between the two leaf-
lets, we calculate that the membrane is thinned by <1 A˚ in
all of our systems.
FIGURE 7 Bilayer curvature indicated by heat maps of phosphate heights relative to neat bilayers and bilayer thickness for clusters of six fengycins and
nine fengycins bound to DPPC and POPC bilayers. The X and Y axes are the distance from the centered fengycin cluster (measured in A˚ngstroms). Extreme
values near the origin reflect the fact that there is some occlusion of lipids by fengycin in one or both leaflets. To see this figure in color, go online.
Fengycin-Bilayer Interactions 1619Fengycin also perturbs bilayer structure by affecting the
order within the lipid bilayer. Our analysis of principal
component-based order parameters calculated as a function
of distance from the lipopeptides shows this disordering
effect (seen in Fig. 10). The molecular order parameter
effectively measures the tilt of the lipid palmitoyl chainsFIGURE 8 Sample images of curvature induced by nine fengycin clus-
ters in both DPPC and POPC bilayers. (Fengycins are green, lipid tails
are yellow, and headgroups for DPPC and POPC are purple and blue,
respectively.)on a scale comparable to standard deuterium order parame-
ters. At distances far from the lipopeptides the curves match
the calculated molecular order parameters from bilayers
without any lipopeptides, indicating the simulated systems
are large enough to recover bulk-like structure at long range.
Near the peptide, the bilayer is significantly perturbed. The
effect is enhanced in the presence of fengycin clusters, both
in strength and range. However, the effect decays relatively
rapidly, and is nearly invisible beyond 40 A˚ from the largest
lipopeptide clusters. Experimental work shows that fengy-
cin has little effect on bulk bilayer order, but has a disrupting
effect locally (47). One model suggests this heterogeneous
perturbation is the result of fengycin’s poor bilayer mixing,
which leads to detergent-rich clusters that cause short-range
order effects (47).
DPPC and POPC, which differ only in one lipid tail, are
affected differently by fengycin, at least for the systems
with only one lipopeptide. The order parameter for DPPC
in those systems drops much more dramatically. This might
be expected, because fengycin has been shown to affect
DPPC compressibility in monolayers and has a fluidizing
effect in DPPC bilayers, while reducing the formation of
condensed domains (13) (this effect is similar to that for
cholesterol (48)).
The order of POPE and POPG lipids is affected differ-
ently as well, despite the fact that they show the same order
in a well-mixed system. Given what we have already seenBiophysical Journal 105(7) 1612–1623
A B C
FIGURE 9 Height of phosphates above the cen-
ter of the bilayer as a function of distance from the
centroid of each fengycin, plotted for both the
proximal and distal leaflets (left and right axes,
respectively) for the (A) DPPC, (B) POPC, and
(C) POPE/POPG systems with 13 fengycins. To
see this figure in color, go online.
1620 Horn et al.about fengycin’s ability to separate POPG and POPE, with a
preference for POPG, it is not surprising that the values
between the two would be different. The effect on POPE
is stronger, suggesting another reason for the preference
for POPG near the lipid surface: to avoid unfavorable
lipid-peptide interactions, the lipid must undergo presum-
ably unfavorable contortions. However, the thermodynamic
significance of this effect is unclear.Limitations of this work and future goals
Improvements to the MARTINI force field might improve
the accuracy of these simulations. For instance, MARTINI
Ver. 2.2 includes changes to proline residues, which have
been shown to be too hydrophobic (49). This would have
some effect, given the importance of amphipathicity to fen-
gycin’s binding and positioning in the bilayer. Also, there
are concerns about the accuracy of electrostatics in our cho-
sen model. Because of the lack of polarity in water and the
absence of partial charges in the system, a screening con-
stant is employed to simulate distance-dependent dielectric
screening. However, this screening is the same strength no
matter the environment, resulting in weak attractions be-
tween oppositely charged residues in apolar mediums (like
the center of the lipid bilayer). This could have an effect
on the lipid-fengycin interactions in our system, especially
in the case of fengycin in the POPE/POPG system where
a huge number of charged moieties exist near the bilayer.A B
Biophysical Journal 105(7) 1612–1623One way to improve this, at the expense of computational
speed, would be to utilize a polarizable water model (50).
There is a large variety of fengycins with differences in
primary sequence, particularly substitutions of glutamine
for the charged Glu8. But even among those with identical
primary sequence, there are differences in chirality of the
side chains, specifically Tyr3 and Tyr9 (51). Exploring the
role of chirality in the mechanism of fengycin is beyond
the resolution of the MARTINI model, which has too few
interaction sites in each amino acid to effectively consider
stereoisomers; going forward, we plan to perform all-atom
simulations to address these questions.
It has also been shown that the ionic environment has an
effect on the structure of fengycin. In particular, calcium
causes changes to fengycin that alters the environment
around the tyrosines as detected by nuclear magnetic reso-
nance (52). We have only explicitly considered NaCl in
our systems, as is commonly done to model physiological
conditions. It would be worth considering the role of ionic
strength on fengycin structure and fengycin binding to bila-
yers (especially the negatively charged POPE/POPG bilayer
system). However, treating the solvation behavior for diva-
lent cations is challenging even for all-atom force fields
that explicitly treat polarization (53), let alone simpler
models such as the one used here.
As a result, future work will definitely include all-atom
simulations of fengycin. These will be challenging, because
membrane binding and lateral reorganization are relativelyFIGURE 10 Principal component-based order
parameters for the palmitoyl chains in the three
systems, with POPE and POPG shown separately,
for the systems with (A) one fengycin and those
with (B) 13 fengycins. (Dashed lines indicate the
value calculated from equivalent fengycin-free sys-
tems.) To see this figure in color, go online.
Fengycin-Bilayer Interactions 1621slow phenomena requiring long trajectories (preferably
multiple independent ones) of relatively large systems.
However, we could speed the process by choosing snapshots
from a number of different system states in our coarse-
grained trajectories and using them to construct equivalent
all-atom systems that can be used to seed new runs. Compar-
ison of these all-atom runs to the coarse-grained results
would help confirm the validity of the models and provide
more detailed information about the interactions between
fengycin and lipids.
We also intend to simulate the same bilayer systems with
dispersed, bound lipopeptides, rather than beginning from a
micelle structure. This would allow us to see if the lipopep-
tides will cluster and form equilibrated aggregates of the
sizes we see from our aggregate dispersion data. Further-
more, we plan to simulate larger bilayer systems to try to
further capture the bilayer curvature effects of the fengycin
molecules. Because of the use of periodic boundary condi-
tions, any curvature in the bilayer is limited to what is
able to fit within the box dimensions. Simulating a box
that is much larger would allow us to see if the curvature
is even greater than what is reported here.
Future simulations must also include more variety in fen-
gycin structures. The fengycin structure chosen for this
work is atypical and the literature on it is sparse. For com-
parison, simulations of fengycin IX (38), a much more com-
mon structure with a deeper literature, would be useful for
more validation with experimental results. Considering the
importance we place on Tyr3 in the aggregation properties
of fengycin, we suggest mutating this residue to a hydropho-
bic, noncyclic residue experimentally to see if this affects
aggregation. Followup simulations will include this test
case, as well as include alanine to valine substitutions at
position 6, a variation among known fengycins. Because
this change is minor, we would not expect a major effect,
but it might result in subtle changes to aggregation and
insertion properties.CONCLUSIONS
According to our coarse-grained simulations, fengycin ag-
gregates in solution and remains in clusters, even during
long timescale simulations. They readily partition into bila-
yers, existing as partially inserted and partially solvent-
exposed. It has been theorized that membranes do not
readily accommodate the large peptide head of fengycin,
leading to partial insertion and a preference for clusters (46).
The predicted clusters form and bind to membranes,
regardless of the headgroup composition, and remain stable
as the peptides insert into zwitterionic PC membranes. By
contrast, in anionic-mixed POPE/POPG systems, the clus-
ters do not persist, but fall apart into a mixture of dimers
and monomers. Further simulation may lead to complete
disintegration of the clusters in those bilayers. Because the
2:1 POPE/POPG bilayer is an effective (if simplified) modelfor bacteria-like membranes, which have high concentra-
tions of PG headgroups and a net negative charge (54),
this suggests a mechanism for how fengycin could avoid
damaging bacterial membranes while attacking those of
fungi. If lipopeptide clustering at higher concentrations
plays a major role in fengycin’s function—our simulations
suggest that fengycin oligomers have much larger effects
on bilayer structure—then this inability to form clusters in
the bacteria-like bilayer might explain fengycin’s specificity
for fungi as opposed to bacteria (1). The fact that the clus-
tering occurs via specific structural motifs further suggests
that this is part of its evolved mechanism.
Fengycin has multiple effects on bilayer systems. We
have shown that fengycin demixes POPE/POPG bilayers,
surprisingly attracting the anionic POPG lipids. We have
quantified pairwise interactions between lipids and residues
that explain this contact despite an anionic peptide and an
anionic lipid. Fengycin also promotes positive curvature in
all of our tested bilayer systems. This effect seems to be
much more dramatic when the fengycins are clustered.
Finally, fengycins also perturb the intrinsic order of the
bilayer locally.
All of this evidence suggests a more complete model for
fengycin-bilayer interactions that is in agreement with
experimental evidence. Fengycin readily aggregates and
binds to lipid bilayers, increasing bilayer fluidity and pro-
moting curvature that could lead to micelle formation. The
concentration of fengycin in our systems is too low to expect
to see major bilayer deformations, but the curvature effects
do appear to be concentration-dependent. At very high con-
centrations, fengycin likely acts as a detergent, but at lower
concentrations that are still above the effective threshold,
fengycin might form oligomeric structures that cause
bilayer perturbation, bending, and micelle formation that
might damage the membrane (13). This process has been
reported for surfactins, which are very similar structurally
to fengycins (55,56).
We have presented a number of long-timescale coarse-
grained simulations that explore the effects of fengycin on
a variety of lipid bilayer systems. We have identified a num-
ber of fengycin-induced bilayer perturbations that are theo-
rized and described in the experimental literature, allowing
us to contribute to the model of activity for fengycin.SUPPORTING MATERIAL
One table, one figure, and Fengycin Cluster Analysis and Curation
are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(13)00981-8.
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